Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (19 ops.)
Latest filing published 21 Mar 2016 for GLOBEIMMUNE INC, €39k.
Insider track record
Disclosed buys
2
Disclosed sells
19
Signal history
No signal scores available.
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
S. Edward Torres: trading record in brief
Filings by S. Edward Torres span 2 companies, the busiest being Receptos, Inc. and Globeimmune Inc. The record holds 27 filings, for trades running from 14 May 2013 to 17 March 2016.
The open-market side counts 2 purchases for €2.2M alongside 19 sales for €79.7M. Sales outweigh purchases by €77.5M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant. 2016 to date brings no purchases and 1 sale.
Most recently, on 21 March 2016, the filings show an open-market sale worth €39k in Globeimmune Inc. The last purchase on record was published on 9 July 2014, which is 4,490 days ago. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to S. Edward Torres
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
26,188 shares@ US$1.67100.0% of flowCommon StockSEC:0001209191-16-109755:0
665,561 sharesCommon StockSEC:0000899243-15-004156:0
7,400 sharesCommon StockSEC:0000899243-15-004156:1
81,200 shares@ US$180.33Common StockSEC:0001209191-15-053996:0
88,400 shares@ US$175.54Common StockSEC:0001209191-15-053996:1
50,400 shares@ US$182.89Common StockSEC:0001209191-15-053996:2
7,400 shares0Common StockSEC:0001209191-15-048578:0
7,200 shares@ US$130.15Common StockSEC:0001209191-15-021850:0
26,400 shares@ US$129.95Common StockSEC:0001209191-15-018813:0
21,953 shares@ US$125.43Common StockSEC:0001209191-15-018054:0
25,953 shares@ US$130.54Common StockSEC:0001209191-15-018054:1
14,318 shares@ US$63.08Common StockSEC:0001209191-14-059710:0
85,682 shares@ US$61.07Common StockSEC:0001209191-14-059710:1
38,917 shares@ US$63.67Common StockSEC:0001209191-14-058922:0
91,513 shares@ US$62.77Common StockSEC:0001209191-14-058922:1
169,570 shares@ US$62.55Common StockSEC:0001209191-14-058922:2
200,000 shares@ US$43.24Common StockSEC:0001209191-14-052749:0
182,894 shares0Common StockSEC:0001209191-14-046566:0
85,000 shares@ US$10.00Common StockSEC:0001209191-14-046566:1
Canonical exit: 6 Oct 2014 (T+90)
24,068 shares@ US$26.25Common StockSEC:0001209191-14-035965:0
344,935 shares@ US$25.18Common StockSEC:0001209191-14-035965:1
55,065 shares@ US$25.33Common StockSEC:0001209191-14-035965:2
64,000 shares@ US$27.80Common StockSEC:0001209191-14-034748:0
26,075 shares@ US$26.32Common StockSEC:0001209191-14-034748:1
672,029 shares@ US$7.73Common StockSEC:0001104659-13-041509:1
25 of 26 declarations
